✦ LIBER ✦

TOWNE-VACCINE-INDUCED PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER RENAL TRANSPLANTS

✍ Scribed by Plotkin, StanleyA.; Friedman, HarveyM.; Fleisher, GaryR.; Dafoe, DonaldC.; Grossman, RobertA.; Lynn Smiley, M.; Starr, StuartE.; Wlodaver, Cliff; Friedman, AllanD.; Barker, ClydeF.

Book ID: 123394999
Publisher: The Lancet
Year: 1984
Tongue: English
Weight: 435 KB
Volume: 323
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(84)90930-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective strategies to prevent cytomega

Effective strategies to prevent cytomegalovirus disease after renal transplantation

✍ J.R Chapman 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Valacyclovir Prophylaxis Versus Preempti

Valacyclovir Prophylaxis Versus Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease After Renal Transplantation

✍ T. Reischig; P. Jindra; O. Hes; M. Švecová; J. Klaboch; V. Třeška 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB

Prevention of Cytomegalovirus Disease in

Prevention of Cytomegalovirus Disease in Renal Transplantation: Single-Center Experience

✍ L. Parreira; M. Bruges; A. Gaspar; A. Weigert; D. Machado 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Quantity of cytomegalovirus viruria is a

Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation

✍ Cope, A. V.; Sweny, P.; Sabin, C.; Rees, L.; Griffiths, P. D.; Emery, V. C. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 2 views

Studies have shown that risk factors for human cytomegalovirus (HCMV) disease after renal transplant include primary infection (virus of donor origin infecting a non-immune individual), re-infection (virus of donor origin infecting a immune individual), and the detection of viraemia (as a marker of

Preemptive Therapy for the Prevention of

Preemptive Therapy for the Prevention of Cytomegalovirus Disease in Renal Transplant Recipients: Our Preliminary Experience

✍ N. Paudice; A. Mehmetaj; M. Zanazzi; L. Moscarelli; R. Piperno; L. Di Maria; E. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Prevention of cytomegalovirus disease af

Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days’ intravenous ganciclovir

✍ M.J Paniagua; M.G Crespo-Leiro; L De la Fuente; T Tabuyo; I Mosquera; A Cañizare 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 44 KB